EXHIBIT 3 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1) promulgated under the Securities and Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with each other on behalf of each of them to a statement on...
EXHIBIT 3
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k)(1) promulgated under the Securities and
Exchange Act of 1934, as amended, the undersigned hereby agree to the joint
filing with each other on behalf of each of them to a statement on Schedule 13D
with respect to the Common Stock, $0.001 par value, of IMPAC Medical Systems,
Inc. beneficially owned by each of them. This Joint Filing Agreement shall be
included as an exhibit to such Schedule 13D.
IN WITNESS THEREOF, the undersigned have caused their duly authorized
representatives to execute this Joint Filing Agreement as of the 27th day of
January, 2005.
ERBIUM ACQUISITION CORPORATION
By: /s/ XXXXX XXXXXXXXX
--------------------------
Name: Xxxxx Xxxxxxxxx
Title: President
ELEKTA HOLDINGS U.S., INC.
By: /s/ XXXXXXX XXXXXXXXX
--------------------------
Name: Xxxxxxx XxXxxxxxx
Title: President
ELEKTA AB (publ)
By: /s/ XXXXX XXXXXXXXX
--------------------------
Name: Xxxxx Xxxxxxxxx
Title: Chief Financial Officer
